Sunshine Database Could Aid Pharma In Defense Against DOJ Suits
Former federal prosecutor Michael Loucks notes that companies can use information about competitors’ payments to physicians in defending themselves against charges they paid to induce prescribing.
You may also be interested in...
Final CMS reg on reporting industry payments to physicians include limiting coverage to companies operating in the U.S. and a definition of third-party payments; despite wins in the revisions from the proposed rule, industry may need a widespread education campaign in order to preserve the value of its physician relationships.
GlaxoSmithKline pleads guilty to marketing Paxil and Wellbutrin off-label and concealing Avandia safety data from FDA and resolves allegations of kickbacks involving nine drugs; ground-breaking corporate integrity agreement includes novel recoup of bonuses from execs if they or their subordinates engage in “significant misconduct.”
Industry also seems supportive of the idea, while Pew touts the power of the power of track-and-trace as a deterrent.